Possible malignant neuroleptic syndrome that associated with hypothyroidism

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 29, Issue 5, 2005, Pages 745-748

  Taskapan, Cagatay ^a   Sahin, Ibrahim ^a   Taskapan, Hulya ^a   Kaya, Burhanettin ^a   Kosar, Feridun ^a  

^a INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Hyponatremia; Hypothyroidism; Malignant neuroleptic syndrome; Neuroleptics; Rhabdomyolysis

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; CLOZAPINE; CREATINE KINASE; FLUPHENAZINE; HALOPERIDOL; HYDROCORTISONE; LACTATE DEHYDROGENASE; LIOTHYRONINE; NEUROLEPTIC AGENT; SODIUM; SODIUM CHLORIDE; THYROTROPIN; THYROXINE;

ACUTE PSYCHOSIS; ADRENAL INSUFFICIENCY; ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; CONFUSION; CREATINE KINASE BLOOD LEVEL; DEPRESSION; DISEASE ASSOCIATION; DISORIENTATION; DRUG WITHDRAWAL; FEMALE; FEVER; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPONATREMIA; HYPOTHYROIDISM; INSOMNIA; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LETHARGY; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA; SODIUM BLOOD LEVEL; SYMPTOM; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; UNCONSCIOUSNESS;

ADRENAL INSUFFICIENCY; ANTIPSYCHOTIC AGENTS; BODY TEMPERATURE; CLOZAPINE; FEMALE; HALOPERIDOL; HUMANS; HYPONATREMIA; HYPOTHYROIDISM; MIDDLE AGED; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; SCHIZOPHRENIA;

EID: 21244455731     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.04.004     Document Type: Article

References (18)

1. F.S. Baajafer, M.M. Hammami, and G.E. Mohamed Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism J. Endocrinol. Invest. 22 1999 35 39
2. C.W. Burke Adrenocortical insufficiency Clin. Endocrinol. Metab. 14 4 1985 947 976
3. A.D. Crocker, and D.L. Cameron Evidence for post-synaptic changes mediating increased behavioural sensitivity to dopamine receptor agonists in hypothyroid rats Prog. Neuro-Psychopharmacol. Biol. Psychiatry 12 5 1988 607 615
4. A.D. Crocker, and D.H. Overstreet Modification of the behavioral effects of haloperidol and of dopamine receptor regulation by altered thyroid status Psychopharmacology Berl 82 1-2 1984 102 106
5. A.D. Crocker, D.H. Overstreet, and J.M. Crocker Hypothyroidism leads to increased dopamine receptor sensitivity and concentration Pharmacol. Biochem. Behav. 24 6 1986 1593 1597
6. P.A. Ellinas, F. Rosner, and J.C. Jaume Symptomatic hyponatremia associated with psychosis, medications, and smoking J. Natl. Med. Assoc. 85 2 1993 135 141
7. J.D. Gradon Neuroleptic malignant syndrome possibly caused by molindone hydrochloride D.I.C.P. 25 10 1991 1071 1072
8. S. Hasan, and P. Buckley Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique Am. J. Psychiatry 155 1998 1113 1116
9. Y. Kaneda, A. Fujii, and T. Ohmori The hypothalamic-pituitary-adrenal axis in chronic schizophrenic patients long-term treated with neuroleptics Prog. Neuro-Psychopharmacol. Biol. Psychiatry 26 5 2002 935 938
10. M. Kawajiri, Y. Ohyagi, H. Furuya, T. Araki, N. Inoue, S. Esaki, T. Yamada, and J. Kira Patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam Rinsho Shinkeigaku. 42 2 2002 136 139
11. A.A. Khaleeli, D.G. Griffith, and R.H.T. Edwards The clinical presentation of hypothyroid myopathy and its relation to abnormalities in structure and function of skeletal muscle Clin. Endocrinol. 19 1983 365 376
12. A. Martinos, P. Rinieris, D.N. Papachristou, A. Souvatzoglou, D.A. Koutras, and C. Stefanis Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients Neuropsychobiology 16 2-3 1986 72 77
13. A.P. Moore, I.A. Macfarlane, and L.D. Blumhardt Neuroleptic malignant syndrome and hypothyroidism J. Neurol. Neurosurg. Psychiatry 53 6 1990 517 518
14. C.G. Roberts, and P.W. Ladenson Hypothyroidism Lancet 6;363 9411 2004 793 803
15. M.F. Sauvage, P. Marquet, A. Rousseau, C. Raby, J. Buxeraud, and G. Lachatre Relationship between psychotropic drugs and thyroid function: a review Toxicol. Appl. Pharmacol. 149 1998 127 135
16. E.L. Siegler, D. Tamres, J.A. Berlin, L. Allen-Taylor, and B.L. Strom Risk factors for the development of hyponatremia in psychiatric patients Arch. Intern. Med. 8;155 9 1995 953 957
17. R.H. Sterns Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases Ann. Intern. Med. 107 1987 656 664
18. D.A. Wirshing Adverse effects of atypical antipsychotic J. Clin. Psychiatry 62 Suppl. 21 2001 7 10